Tech Company Financing Transactions
Metastatix Funding Round
Frazier Healthcare Partners, Aurora Funds and Georgia Venture Partners joined a $35 million Series B venture round for Metastatix. The funding round was announced on 10/9/2007.
Transaction Overview
Company Name
Announced On
10/9/2007
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series B
Investors
Proceeds Purpose
The new round of funding primarily will be used to conduct clinical trials of the company's lead candidate, MSX-122, in cancer patients and to advance the company's development programs in inflammation and HIV infection.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
311 Ferst Drive NW
Atlanta, GA 30332
USA
Atlanta, GA 30332
USA
Phone
Website
Email Address
Not Recorded
Overview
Metastatix, Inc. is a privately held pharmaceutical company based in Atlanta, GA.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Carol Gallagher
Co-Founder
Dennis Liotta
Co-Founder
Hyunsuk Shim
Co-Founder
Jim Snyder
VP - R & D
Mike Natchus
Browse more venture capital transactions:
Prev: 10/8/2007: Assay Depot venture capital transaction
Next: 10/9/2007: Spinal Restoration venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs